Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: patient selection and special considerations
Sheel A Patel, Jean Hoffman-Censits Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA Abstract: Cabazitaxel is an effective chemotherapeutic agent used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) refracto...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-08-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/cabazitaxel-in-the-treatment-of-metastatic-castration-resistant-prosta-peer-reviewed-article-OTT |